# Phio Pharmaceuticals Corp.: Form 8-K, filed Nov 30, 2016

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2016-11-30
- Accepted by EDGAR: Nov 29, 2016, 21:51 ET
- Period: 2016-11-29
- Accession: 0001193125-16-779955
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312516779955/d299060d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312516779955/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312516779955/d299060d8k.htm

Filed Nov 30, 2016.
Source: SEC EDGAR, the filing index for accession 0001193125-16-779955. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
